NCT06908707 A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women Status COMPLETED Phase PHASE1
NCT06906640 Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) Status RECRUITING Phase NA
NCT06906627 Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD) Status RECRUITING Phase NA
NCT06901518 The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous Headaches Status COMPLETED Phase PHASE4
NCT06901349 A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes Status WITHDRAWN Phase PHASE2
NCT06897475 A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide Status RECRUITING Phase PHASE2
NCT06896162 PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival Status RECRUITING Phase NA
NCT06890611 A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants Status COMPLETED Phase PHASE1
NCT06890598 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06876662 A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma Status RECRUITING Phase PHASE4
NCT06876649 A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib Status RECRUITING Phase PHASE4
NCT06869018 A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants Status COMPLETED Phase PHASE1
NCT06868381 A Trial of Baricitinib in Patients With Cardiac Sarcoidosis Status NOT_YET_RECRUITING Phase PHASE2
NCT06864403 Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch Status RECRUITING Phase PHASE4
NCT06864026 A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) Status RECRUITING Phase PHASE4
NCT06859294 A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06859268 A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06857942 A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO) Status RECRUITING Phase PHASE4
NCT06855212 Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06847399 Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder Status RECRUITING Phase PHASE2